Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress

Food and Chemical Toxicology

Volumn 46, Issue 5, 2008, Pages 1510-1515

  Jiang, Baohong ^a   Zhang, Lin ^a   Li, Ming ^a   Wu, Wanying ^a   Yang, Min ^a   Wang, Junchen ^b   Guo, De an ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Cardioprotection; Doxorubicin; Free radical; Salvianolic acids

Indexed keywords

CREATINE KINASE; DOXORUBICIN; MALONALDEHYDE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE; SALVIANOLIC ACID B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; ELECTROCARDIOGRAM; HEART INJURY; HEART PROTECTION; HEART WEIGHT; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; TIBIA; WEIGHT GAIN;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BENZOFURANS; BODY WEIGHT; CAFFEIC ACIDS; CARDIOTONIC AGENTS; CREATINE KINASE; DOXORUBICIN; ELECTROCARDIOGRAPHY; HEART DISEASES; LACTATES; MALE; MALONDIALDEHYDE; MICE; MYOCARDIUM; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TISSUE FIXATION;

MUS;

EID: 40849123983     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.12.020     Document Type: Article

References (22)

1. Adams J.D., Wang R.B., Yang J., and Lien E.J. Preclinical and clinical examinations of salvia miltiorrhiza and its Tanshinones in ischemic conditions. Chin. Med. 23 (2006) 1-15
2. Cao G., and Prior R.L. Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol. 299 (1999) 50-62
3. Chen Y.L., Hu C.S., Lin F.Y., Chen Y.H., Sheu L.M., Ku H.H., Shiao M.S., Chen J.W., and Lin S.J. Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta. J. Cell Biochem. 98 (2006) 618-631
4. den Hartog G.J., Haenen G.R., Boven E., wan der Vijgh W.J., and Bast A. Lecithinized copper, zinc-superoxide dismutase as a protector against doxorubicin-induced cardiotoxicity in mice. Toxicol. Appl. Pharmacol. 194 (2004) 180-188
5. Ferreira A.L., Salvadori D.M., Nascimento M.C., Rocha N.S., Correa C.R., Pereira E.J., Matsubara L.S., Matsubara B.B., and Ladeira M.S. Tomato-oleoresin supplement prevents doxorubicin-induced cardiac myocyte oxidative DNA damage in rats. Mutat. Res. 631 (2007) 26-35
6. Franco F., Dubois S.K., Peshock R.M., and Shohet R.V. Magnetic resonance imaging accurately estimates LV mass in a transgenic mouse model of cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 274 (1998) H679-H683
7. Gill C., Mestril R., and Samali A. Losing Heart: the role of apoptosis in heart disease - a novel therapeutic target. FASEB 20 (2002) 135-146
8. Jang Y.M., Kendaiah S., Drew B., Phillips T., Selman C., Julian D., and Leeuwenburgh C. Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett. 577 (2004) 483-490
9. L'Ecuyer T., Sanjeev S., Thomas R., Novak R., Das L., Campbell W., and Heide R.V. DNA damage is an early event in doxorubicin-induced cardiac myocyte death. Am. J. Physiol. Heart. Circ. Physiol. 291 (2006) H1273-H1280
10. Lam F.F., Yeung J.H., Kwan Y.W., Chan K.M., and Or P.M. Salvianolic acid B, an aqueous component of danshen (Salvia miltiorrhiza), relaxes rat coronary artery by inhibition of calcium channels. Eur. J. Pharmacol. 553 (2006) 240-245
11. Li K., Sung R.Y.T., Huang W.Z., Yang M., Pong N.H., Lee S.M., Chan W.Y., Zhao H., Zhao H., To M.Y., Fok T.F., Li C.K., Wong Q.Y., and Ng P.C. Thromboprotein protects against in vitro and in vivo cardiotoxicity induced by doxorubicin. Circulation 113 (2006) 2211-2220
12. Lin T.J., Liu G.T., Liu Y., and Xu G.Z. Protection by salvianolic acid A against adriamycin toxicity on rat heart mitochondria. Free Radic. Biol. Med. 12 (1992) 347-351
13. Liu A.H., Li L., Xu M., Guo H.Z., Wu W.Y., and Guo D.A. Simultaneous quantification of six major phenolic acids in the roots of Salvia miltiorrhiza and four related traditional Chinese medicinal preparations by HPLC-DAD method. J. Pharma. Biomed. Anal. 41 (2006) 48-56
14. Liu A.H., Lian Y., Lin Y.H., Wu W.Y., Sun J.H., and Guo D.A. Detection, characterization and identification of phenolic acids in Danshen using high-performance liquid chromatography with diode array detection and electrospray ionization mass spectrometry. J. Chromatogr. A. 1161 (2007) 170-182
15. Ng R., and Green M.D. Managing cardiotoxicity in anthracycline-treated breast cancers. Expert. Opin. Drug. Saf. 6 (2007) 315-321
16. Olson R.D., and Mushlin P.S. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4 (1990) 3076-3086
17. Papadopoulou L.C., Theophilidis G., Thomopoulos G.N., and Tsiftsoglou A.S. Structural and functional impairment of mitochondria in adriamycin-induced cardiomyopathy in mice: suppression of cytochrome c oxidase II gene expression. Biochem. Pharmacol. 57 (1999) 481-489
18. Shi C.S., Huang H.C., Wu H.L., Kuo C.H., Chang B.I., Shiao M.S., and Shi G.Y. Salvianolic acid B modulates hemostasis properties of human umbilical vein endothelial cell. Thromb. Res. 119 (2007) 769-775
19. Takemura G., and Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog. Cardiovasc. Dis. 49 (2007) 330-352
20. Tang M.K., Ren D.C., Zhang J.T., and Du G.H. Effect of salvianolic acids from radix salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 9 (2002) 405-409
21. Wang C.Y., Ma F.L., Liu J.T., Tian J.W., and Fu F.H. Protective effect of salvianic acid A on acute liver injury induced by carbon tetrachloride in rats. Biol. Pharm. Bull. 30 (2007) 44-47
22. Zhou L., Zuo Z., and Chow M.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 45 (2005) 1345-1359